Type ? Target MUC1 Routes of
administration Intraperitoneal | Source Mouse Trade names Theragyn ATC code none | |
Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour. As of 2009, it is undergoing Phase III clinical trials.
It has been granted orphan drug status in Europe.
References
Pemtumomab Wikipedia(Text) CC BY-SA